인간 간 모델 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Human Liver Models Market size was valued at USD 1.38 Billion in 2024 and is poised to grow from USD 1.58 Billion in 2025 to USD 4.73 Billion by 2033, growing at a CAGR of 14.7% during the forecast period (2026-2033).

The global human liver model market is poised for significant growth, driven by heightened demand for drug toxicity testing and a strong push towards minimizing animal testing. Factors such as increased investments in regenerative medicine and advancements in 3D liver modeling technologies are contributing to this expansion. Furthermore, the rising prevalence of liver diseases and the growing emphasis on personalized medicine are amplifying the necessity for precise and dependable drug testing alternatives. Despite this promising outlook, challenges remain, including the high costs associated with advanced liver model technologies, a shortage of skilled personnel, and the complex nature of implementation. Additionally, regulatory hurdles and inconsistencies in model validation may impede widespread adoption, potentially affecting market penetration and growth rates in various regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Human Liver Models market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Human Liver Models Market Segments Analysis

Global Human Liver Models Market is segmented by Product Type, Application, End-User and region. Based on Product Type, the market is segmented into 2D Models, 3D Models, Liver-on-a-Chip / Micro-fluidic Models and Ex-Vivo / Tissue Slice Models. Based on Application, the market is segmented into ADME Studies, Toxicology / Safety Testing, Disease Modelling and Others. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organisations (CROs) and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Human Liver Models Market

The increasing need for precise and prompt assessment of drug toxicity serves as a significant catalyst for the expansion of the human liver models market. These models provide enhanced physiological relevance and predictive accuracy, enabling pharmaceutical companies to detect potential toxicities earlier in the development process. This crucial capability allows for greater confidence in advancing drug candidates through various stages of development, ultimately contributing to more efficient and effective drug evaluation and approval. As a result, the market for human liver models is witnessing considerable growth, driven by the necessity for improved testing methodologies in the pharmaceutical industry.

Restraints in the Global Human Liver Models Market

The Global Human Liver Models market faces challenges due to the substantial financial investments required for the creation and maintenance of advanced liver models, including liver-on-a-chip systems and three-dimensional printed tissues. The need for specialized equipment, a highly skilled workforce, and quality materials can lead to significant costs that may be overwhelming for smaller laboratories or institutions with limited budgets. This financial burden can hinder market entry and accessibility, particularly in developing regions where resources are scarce, thus restricting the adoption of innovative technologies that could otherwise enhance research and development in the field.

Market Trends of the Global Human Liver Models Market

The Global Human Liver Models market is witnessing significant growth driven by technological advancements in 3D bioprinting and organ-on-a-chip platforms. These innovations enhance the precision of drug screening processes, minimizing reliance on traditional animal testing and enabling researchers to replicate intricate liver diseases more accurately. This evolution not only streamlines drug discovery and development but also supports more effective disease research, positioning human liver models as essential tools in pharmaceutical and biomedical fields. The emphasis on reducing ethical concerns associated with animal models further fuels the demand for these sophisticated liver models, indicating a promising trajectory for the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Human Liver Models Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• 2D Models
• 3D Models
• Liver-on-a-Chip / Micro-fluidic Models
• Ex-Vivo / Tissue Slice Models

Global Human Liver Models Market Size by Application & CAGR (2026-2033)

• Market Overview
• ADME Studies
• Toxicology / Safety Testing
• Disease Modelling
• Others

Global Human Liver Models Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Contract Research Organisations (CROs)
• Academic & Research Institutes

Global Human Liver Models Market Size & CAGR (2026-2033)

• North America (Product Type, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• ATCC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AcceGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZenBio, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organovo Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioIVT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSphero
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CN Bio Innovations Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScienCell Research Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emulate, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyfuse Biomedical K.K.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mimetas
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellink
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PhoenixBio Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BICO Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kirkstall Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MATTEK (The BICO Group)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiREL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations